组合性大脑分数捕捉阿尔茨海默氏症特定的结构性大脑模式沿着疾病连续性的疾病连续
Patricia Genius1,2,3,4, M Luz Calle5, Blanca Rodríguez-Fernández1,2,3
1Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|January 27, 2025
概括
组合数据分析 (CoDA) 揭示了阿尔茨海默病 (AD) 和遗传学如何影响大脑结构. 这种方法可以在AD阶段识别不同的大脑模式,并揭示大脑形态学上的更广泛的遗传影响.
科学领域:
- 神经成像是一种神经成像.
- 阿尔茨海默氏症疾病研究研究
- 遗传学 遗传学 是一个
背景情况:
- 传统的多变量方法往往无法在神经成像研究中捕捉大脑特征之间的相互依存关系.
- 阿尔茨海默氏症 (AD) 和遗传因素在疾病连续链中显著影响大脑结构.
研究的目的:
- 用组合数据分析 (CoDA) 分析相对大脑体积图案,以了解AD对大脑结构的影响.
- 研究遗传风险因素如何影响AD不同阶段的大脑形态.
主要方法:
- 利用了来自阿尔茨海默病和家庭 (ALFA) 和阿尔茨海默病神经成像计划 (ADNI) 研究的数据.
- 应用CoDA来检查与AD阶段和遗传风险相关的相对大脑体积变化.
- 对比阿尔茨海默氏症进展组与认知无损的粉样蛋白β负 (CU A-) 个体.
主要成果:
- 确定了疾病阶段特定的组成大脑分数,区分了CU A-个体与晚期AD阶段的个体.
- 揭示了影响AD大脑形态的更广泛的遗传景观,超出APOE ε4等位基因.
- 证明了CoDA能够在没有严格协调的情况下整合来自多个队伍的数据的能力.
结论:
- CoDA提供了一个新的多变量框架,用于理解AD相关的结构性大脑变化.
- 这种方法可以识别有针对性干预的更高遗传风险的个体.
- 在神经成像研究中,CoDA提高了交叉研究比较的可靠性.
关键词:
阿尔茨海默病遗传倾向 遗传倾向 阿尔茨海默病遗传倾向大脑成像 遗传学 遗传学组成的大脑得分 组成的大脑得分组合数据分析数据分析.多种现象型分析分析神经退行症的神经退行症多基因风险评分多基因风险评分更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.1K
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
39.7K
相关概念视频
01:26Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439
01:30Dementia
92
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
92
01:14Brain Imaging
204
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
204
01:22Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160